Adalimumab – safe and effective therapy for adolescent patient with severe psoriasis and immune thrombocytopenia.

We report the case of an adolescent with severe psoriasis and concomitant immune thrombocytopenia who obtained remission during treatment with adalimumab. Increased concentration of tumor necrosis factor- α seems to be a pathogenic linkage and therapeutic target for both diseases. 
Source: Acta Dermatovenerologica Croatica - Category: Dermatology Source Type: research